163 related articles for article (PubMed ID: 9893058)
1. C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities.
Chen CH; Lam CF; Boackle RJ
Immunology; 1998 Dec; 95(4):648-54. PubMed ID: 9893058
[TBL] [Abstract][Full Text] [Related]
2. A newly discovered function for C1 inhibitor, removal of the entire C1qr2s2 complex from immobilized human IgG subclasses.
Chen CH; Boackle RJ
Clin Immunol Immunopathol; 1998 Apr; 87(1):68-74. PubMed ID: 9576012
[TBL] [Abstract][Full Text] [Related]
3. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
Boackle RJ; Connor MH; Vesely J
Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
[TBL] [Abstract][Full Text] [Related]
5. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q.
Hoekzema R; Martens M; Brouwer MC; Hack CE
Mol Immunol; 1988 May; 25(5):485-94. PubMed ID: 3261834
[TBL] [Abstract][Full Text] [Related]
6. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
7. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.
Su H; Boackle RJ
Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953
[TBL] [Abstract][Full Text] [Related]
9. Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.
Hwang HY; Duvall MR; Tomlinson S; Boackle RJ
Mol Immunol; 2008 May; 45(9):2570-80. PubMed ID: 18313756
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
11. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
12. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
13. Rat polymeric IgA binds C1q, but does not activate C1.
Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
[TBL] [Abstract][Full Text] [Related]
14. Improved method for measuring C1-r-C1-s-(C1 inh)2 complexes by an enzyme-linked immunosorbent assay.
Mathews KP; Herschbach JH; Chambers SL; Zuraw BL
J Clin Lab Anal; 1995; 9(3):196-203. PubMed ID: 7602428
[TBL] [Abstract][Full Text] [Related]
15. Activation of C1 by monoclonal antibodies directed against C1q.
Kilchherr E; Schumaker VN; Curtiss LK
Biochem Biophys Res Commun; 1985 Jan; 126(2):785-91. PubMed ID: 3872122
[TBL] [Abstract][Full Text] [Related]
16. Antibody-independent C1 activation by E. coli.
Tenner AJ; Ziccardi RJ; Cooper NR
J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
[TBL] [Abstract][Full Text] [Related]
17. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
Windfuhr JP; Alsenz J; Loos M
Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
[TBL] [Abstract][Full Text] [Related]
18. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
19. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
Bindon CI; Hale G; Brüggemann M; Waldmann H
J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]